News

InnoStrat Featured in Berlingske

6 December 2025

In December 2025 InnoStrat was featured in an extensive article on the front page of Berlingske Business, one of Denmark’s leading business publications. The article chronicles the journey from InnoStrat’s founding in 2020 to its current position as a specialized consultancy for the pharmaceutical industry.

Berlingske tells the story of how founder Jan Kildeskov and co-founder Mikkel Nielsen – both with extensive experience from big-pharma companies – identified a gap in the market: mid-sized pharmaceutical companies that want professional product launches but lack the same resources as the industry giants.

The article describes InnoStrat’s unique approach, where the focus is on implementation rather than just strategy, and where pharma insiders ensure deep industry knowledge. With specialized expertise in medical affairs, clinical trials, and commercial strategies, InnoStrat helps companies build their own “mini-version” of what the large players can deliver.

Today, InnoStrat has 15 employees, partnerships with two of the world’s top CROs, and funding from EIFO for continued international growth.

📩 The article is available at berlingske.dk (subscription required, in Danish).

Our company is credit worthy according to Bisnode's credit assessment system that is based on a number of decision rules. This credit rating is updated on a daily basis, and always shows the current rating and date.